B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis
Author(s) -
Víctor Llombart,
Albert Antolin-Fontes,
Alejandro Bustamante,
Dolors Giralt,
Natalia S. Rost,
Karen L. Furie,
Kensaku Shibazaki,
Murat Biteker,
José Castillo,
Manuel RodríguezYáñez,
Ana Catarina Fonseca,
Tetsu Watanabe,
Francisco Purroy,
Zhixin Wu,
Thorleif Etgen,
Naohisa Hosomi,
Scott Reza Jafarian Kerman,
Jagdish C. Sharma,
Carolin Knauer,
Estevo Santamarina,
George Giannakoulas,
Teresa GarcíaBerrocoso,
Joan Montaner
Publication year - 2015
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.114.008311
Subject(s) - medicine , natriuretic peptide , stroke (engine) , cardiology , quartile , brain natriuretic peptide , logistic regression , area under the curve , prospective cohort study , heart failure , confidence interval , mechanical engineering , engineering
Determining the underlying cause of stroke is important to optimize secondary prevention treatment. Increased blood levels of natriuretic peptides (B-type natriuretic peptide/N-terminal pro-BNP [BNP/NT-proBNP]) have been repeatedly associated with cardioembolic stroke. Here, we evaluate their clinical value as pathogenic biomarkers for stroke through a literature systematic review and individual participants' data meta-analysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom